Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -28.13M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.02
Volume 182,300
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A
BoJoe
BoJoe Jun. 13 at 8:40 AM
$VRXA $VRXAW the mispricing here is astounding, in both actually. Warrants should technically be at eight bucks right now, with shares at $20 and strike at $11.50. However, the stock is now way too high. At roughly 140m fully diluted share count, we get a marketcap of just under 3bn. Thats simply too much for an early stage biotech with no/little clinical proof. Xlife, a VC firm with a 19% stake had this last valued at 600m.
0 · Reply
Latest News on VRXAW
No data available.
BoJoe
BoJoe Jun. 13 at 8:40 AM
$VRXA $VRXAW the mispricing here is astounding, in both actually. Warrants should technically be at eight bucks right now, with shares at $20 and strike at $11.50. However, the stock is now way too high. At roughly 140m fully diluted share count, we get a marketcap of just under 3bn. Thats simply too much for an early stage biotech with no/little clinical proof. Xlife, a VC firm with a 19% stake had this last valued at 600m.
0 · Reply